In a rare move, the U.S. agency behind Medicare is warning Medicare Advantage providers they can’t have blanket policies that deny coverage of Qalsody because it’s “experimental and investigational.”
CMS says private Medicare plans can’t automatically deny Biogen’s ALS drug
